Basic Information
RNALocate ID: | RLID:02001152 |
RNA Symbol: | MEG3 |
Localization: | Nucleus |
RNA Information
RNA Name: | MEG3 |
RNA ID: | NCBI:55384|Ensembl:ENSG00000214548 |
RNA Category: | lncRNA |
Species: | Homo sapiens |
Alias: | FP504|GTL2|LINC00023|NCRNA00023|PRO0518|PRO2160|onco-lncRNA-83|prebp1 |
Localization Information
PubMed ID: | 32841649 |
Tissue/Cell Line: | Human lens epithelial cells (SRA01/04) |
Method: | FISH|qRT-PCR |
Description: | Next, MEG3 expression was positive in both the cytoplasm and nucleus of SRA01/04 cells (Fig. 3A and B). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:02000599 | Cytoplasm | Hepatoma cells | 21625215 |
RLID:02000600 | Endoplasmic reticulum | Human myelogenous leukemia cell line (K-562) | 21613539 |
RLID:02000601 | Nucleus | Cell line (BT-549) | 26205790 |
RLID:02000602 | Nucleus | HeLa cells | 31107149 |
RLID:02000603 | Nucleus | Cell lines (GM12878|HeLaS3|HepG2)|Human umbilical vein endothelial cells | 22955988 |
RLID:02000604 | Nucleus | Lung fibroblasts | 25630241 |
RLID:02001151 | Cytoplasm | Human lens epithelial cells (SRA01/04) | 32841649 |
RLID-D:12005230 | Exosome | Serum |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | MEG3 | Phaeochromocytoma | MNDR-E-LNC-17886 |
MNDR | MEG3 | Renal fibrosis | MNDR-E-LNC-17887 |
MNDR | MEG3 | Tongue squamous cell carcinoma | MNDR-E-LNC-17888 |
MNDR | MEG3 | Oral squamous cell carcinoma | MNDR-E-LNC-17889 |
MNDR | MEG3 | Myelodysplastic syndrome | MNDR-E-LNC-17890 |
MNDR | MEG3 | Prostate cancer | MNDR-E-LNC-17891 |
MNDR | MEG3 | Hirschsprung disease | MNDR-E-LNC-17892 |
MNDR | MEG3 | Gastric cancer | MNDR-E-LNC-17893 |
MNDR | MEG3 | Pre-eclampsia | MNDR-E-LNC-17894 |
MNDR | MEG3 | Bladder cancer | MNDR-E-LNC-17895 |
MNDR | MEG3 | Huntington disease | MNDR-E-LNC-17896 |
MNDR | MEG3 | Cardiovascular disease | MNDR-E-LNC-17897 |
MNDR | MEG3 | Lung cancer | MNDR-E-LNC-17898 |
MNDR | MEG3 | Endometrial cancer | MNDR-E-LNC-17899 |
MNDR | MEG3 | Metabolic syndrome | MNDR-E-LNC-17900 |
MNDR | MEG3 | Breast cancer | MNDR-E-LNC-17901 |
MNDR | MEG3 | Cancer | MNDR-E-LNC-17902 |
MNDR | MEG3 | Ventricular septal defect | MNDR-E-LNC-17903 |
MNDR | MEG3 | Thyroid cancer | MNDR-E-LNC-17904 |
MNDR | MEG3 | Clinical nonfunctioning pituitary adenoma | MNDR-E-LNC-17905 |
MNDR | MEG3 | Pancreatic cancer | MNDR-E-LNC-17906 |
MNDR | MEG3 | Pancreatic endocrine carcinoma | MNDR-E-LNC-17907 |
MNDR | MEG3 | Pancreatic neuroendocrine tumor | MNDR-E-LNC-17908 |
MNDR | MEG3 | Melanoma | MNDR-E-LNC-17909 |
MNDR | MEG3 | Atherosclerosis | MNDR-E-LNC-17910 |
MNDR | MEG3 | Vulva squamous cell carcinoma | MNDR-E-LNC-17911 |
MNDR | MEG3 | Epithelial ovarian cancer | MNDR-E-LNC-17912 |
MNDR | MEG3 | Nephroblastoma | MNDR-E-LNC-17913 |
MNDR | MEG3 | Colon cancer | MNDR-E-LNC-17914 |
MNDR | MEG3 | Ovarian cancer | MNDR-E-LNC-17915 |
MNDR | MEG3 | Hemangioma | MNDR-E-LNC-17916 |
MNDR | MEG3 | Kidney cancer | MNDR-E-LNC-17917 |
MNDR | MEG3 | Carcinoma endometrial | MNDR-E-LNC-17918 |
MNDR | MEG3 | Laryngeal squamous cell cancer | MNDR-E-LNC-17919 |
MNDR | MEG3 | Glioblastoma | MNDR-E-LNC-17920 |
MNDR | MEG3 | Glioma | MNDR-E-LNC-17921 |
MNDR | MEG3 | Chronic obstructive pulmonary disease | MNDR-E-LNC-17922 |
MNDR | MEG3 | Gallbladder cancer | MNDR-E-LNC-17923 |
MNDR | MEG3 | Embryonal rhabdomyosarcoma | MNDR-E-LNC-17924 |
MNDR | MEG3 | Osteosarcoma | MNDR-E-LNC-17925 |
MNDR | MEG3 | Pancreatic ductal adenocarcinoma | MNDR-E-LNC-17926 |
MNDR | MEG3 | Meningioma | MNDR-E-LNC-17927 |
MNDR | MEG3 | Liver cancer | MNDR-E-LNC-17928 |
MNDR | MEG3 | Choriocarcinoma | MNDR-E-LNC-17929 |
MNDR | MEG3 | Gastric adenocarcinoma | MNDR-E-LNC-17930 |
MNDR | MEG3 | Esophagus squamous cell carcinoma | MNDR-E-LNC-17931 |
MNDR | MEG3 | Non-functioning pituitary adenoma | MNDR-E-LNC-17932 |
MNDR | MEG3 | Lung squamous cell carcinoma | MNDR-E-LNC-17933 |
MNDR | MEG3 | Carcinoma lung non-small-cell | MNDR-E-LNC-17934 |
MNDR | MEG3 | Lung adenocarcinoma | MNDR-E-LNC-17935 |
MNDR | MEG3 | Thyroid carcinoma | MNDR-E-LNC-17936 |
MNDR | MEG3 | Papillary thyroid cancer | MNDR-E-LNC-17937 |
MNDR | MEG3 | Bladder urothelial carcinoma | MNDR-E-LNC-17938 |
MNDR | MEG3 | Valvulopathy | MNDR-E-LNC-17939 |
MNDR | MEG3 | Liver disease | MNDR-E-LNC-17940 |
MNDR | MEG3 | Cervical cancer | MNDR-E-LNC-17941 |
MNDR | MEG3 | Renal cell carcinoma | MNDR-E-LNC-17942 |
MNDR | MEG3 | Clear cell renal cell carcinoma | MNDR-E-LNC-17943 |
MNDR | MEG3 | Cholangiocarcinoma | MNDR-E-LNC-17944 |
MNDR | MEG3 | Myelofibrosis | MNDR-E-LNC-17945 |
MNDR | MEG3 | Esophageal cancer | MNDR-E-LNC-17946 |
MNDR | MEG3 | Liver cirrhosis | MNDR-E-LNC-17947 |
MNDR | MEG3 | Head and neck squamous cell carcinoma | MNDR-E-LNC-17948 |
MNDR | MEG3 | Testicular germ cell cancer | MNDR-E-LNC-17949 |
MNDR | MEG3 | Functionless pituitary adenoma | MNDR-E-LNC-17950 |
MNDR | MEG3 | Gastric cardia adenocarcinoma | MNDR-E-LNC-17951 |
MNDR | MEG3 | Hypoxia-induced pulmonary hypertension | MNDR-E-LNC-17952 |
MNDR | MEG3 | Pulmonary hypertension | MNDR-E-LNC-17953 |
MNDR | MEG3 | Cerebrovascular disease | MNDR-E-LNC-17954 |
MNDR | MEG3 | Hepatocellular carcinoma | MNDR-E-LNC-17955 |
MNDR | MEG3 | Cervical carcinoma | MNDR-E-LNC-17956 |
MNDR | MEG3 | Intraductal papillary mucinous neoplasms of the pancreas | MNDR-E-LNC-17957 |
MNDR | MEG3 | Retinoblastoma | MNDR-E-LNC-17958 |
MNDR | MEG3 | Neuroblastoma | MNDR-E-LNC-17959 |
MNDR | MEG3 | Osteoarthritis | MNDR-E-LNC-17960 |
MNDR | MEG3 | Chronic myeloid leukemia | MNDR-E-LNC-17961 |
MNDR | MEG3 | Immune thrombocytopenia | MNDR-E-LNC-17962 |
MNDR | MEG3 | Acute myeloid leukemia | MNDR-E-LNC-17963 |
MNDR | MEG3 | Colorectal cancer | MNDR-E-LNC-17964 |
MNDR | MEG3 | Nasopharyngeal carcinoma | MNDR-E-LNC-17965 |
MNDR | MEG3 | Nasopharynx carcinoma | MNDR-E-LNC-17966 |
MNDR | MEG3 | Diabetes mellitus | MNDR-E-LNC-17967 |
MNDR | MEG3 | Multiple myeloma | MNDR-E-LNC-17968 |
MNDR | MEG3 | Type 1 diabetes mellitus | MNDR-E-LNC-17969 |
MNDR | MEG3 | Heroin dependence | MNDR-E-LNC-17970 |
MNDR | MEG3 | Ovarian epithelial cancer | MNDR-E-LNC-17971 |
MNDR | MEG3 | Esophageal squamous cell cancer | MNDR-E-LNC-17972 |
MNDR | MEG3 | Uterine cervical neoplasms | MNDR-E-LNC-17973 |
MNDR | MEG3 | Liver fibrosis | MNDR-E-LNC-17974 |
MNDR | MEG3 | Nasopharyngeal cancer | MNDR-E-LNC-17975 |
MNDR | MEG3 | Prostate | MNDR-E-LNC-17976 |
MNDR | MEG3 | Purpura thrombocytopenic | MNDR-E-LNC-17977 |
MNDR | MEG3 | Stroke | MNDR-E-LNC-17978 |
MNDR | MEG3 | T-cell lymphoblastic lymphoma | MNDR-E-LNC-17979 |
MNDR | MEG3 | Liver ischemia/reperfusion(i/r)injury | MNDR-E-LNC-17980 |
MNDR | MEG3 | Spiral artery remodeling | MNDR-E-LNC-17981 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCB1 | Homo sapiens | RR00022756 |
TOP